Form 4: Revelation Biosciences Director Jess Roper Acquires Shares
SEC Form 4 Filing
Director Jess Roper acquired 181 shares of Revelation Biosciences, Inc. at $3.87 per share on February 11, 2025.
Summary
- On February 11, 2025, Jess Roper, a director of Revelation Biosciences, Inc., acquired 181 shares of common stock.
- The shares were purchased at a price of $3.87 per share.
- Following the transaction, Roper directly owns 183 shares of Revelation Biosciences, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. It's neither positive nor negative from an investment perspective without additional context.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders (officers, directors, and 10% owners) buy or sell their company's stock. They provide transparency into the transactions of those with privileged information.
Stakeholder Impact
- The transaction could have a minor impact on shareholder confidence, depending on how the market interprets the insider's purchase.
Key Dates
| Date | Description |
|---|---|
| 02/11/2025 | Date of transaction: Jess Roper acquired shares of Revelation Biosciences, Inc. |
| 02/13/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Revelation Biosciences, REVB, Insider Trading, Jess Roper, Director, Share Acquisition, Equity Incentive Plan, Restricted Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.